Wolverine Ultra - KLOW (KPV, GHK-Cu, BPC-157, TB-500)
GHK-Cu + KPV + BPC-157 + TB-500 (Thymosin β4 fragment) This combination is popular in regenerative medicine and biohacking because it targets healing, inflammation, tissue repair, and cosmetic improvement through different pathways. Subcutaneous
- 200–500 mcg, 1–3× daily
- 4–6 weeks “on,” then reassess
BPC157 10mg / TB500 10mg Wolverine Jr. Blend (20mg)
-
TB-500: Studied for promoting angiogenesis, cell migration, and muscle/tissue regeneration.
-
BPC-157: Investigated for its role in gut healing, anti-inflammatory activity, and soft tissue repair.
-
The combined formulation may be studied for synergistic effects on recovery, wound healing, and tissue regeneration in preclinical models.
-
Accelerates healing of tendons, ligaments, joints, and muscle
-
Reduces inflammation and promotes cellular regeneration
-
Improves mobility, flexibility, and soft tissue resilience
-
Combines localized (BPC) and systemic (TB-500) recovery effects
-
Ideal for post-injury protocols or ongoing support during heavy training
-
Not approved for clinical use in humans or animals.
